首页|期刊导航|脑出血(英文)|Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022:The impact of clazosentan and treatment modalities on outcomes

Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022:The impact of clazosentan and treatment modalities on outcomesOA

Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022:The impact of clazosentan and treatment modalities on outcomes

Hajime Maeda;Tsuyoshi Izumo;Kazuaki Okamura;Susumu Yamaguchi;Yoichi Morofuji;Takayuki Matsuo

Department of Neurosurgery,Nagasaki University Graduate School of Biomedical Sciences,Nagasaki 852-8501,Japan||Department of Neurosurgery,Nagasaki Rosai Hospital,Nagasaki 857-0134,JapanDepartment of Neurosurgery,Nagasaki University Graduate School of Biomedical Sciences,Nagasaki 852-8501,JapanDepartment of Neurosurgery,Nagasaki University Graduate School of Biomedical Sciences,Nagasaki 852-8501,JapanDepartment of Neurosurgery,Sasebo City General Hospital,Nagasaki 857-8511,JapanDepartment of Neurosurgery,Nagasaki University Graduate School of Biomedical Sciences,Nagasaki 852-8501,JapanDepartment of Neurosurgery,Nagasaki University Graduate School of Biomedical Sciences,Nagasaki 852-8501,Japan

Subarachnoid hemorrhageRebleedingGeneral anesthesiaMortalityPreoperative management

Subarachnoid hemorrhageRebleedingGeneral anesthesiaMortalityPreoperative management

《脑出血(英文)》 2024 (2)

3-9,7

We would like to thank all the members who supported the Nagasaki SAH Registry Study and Editage(www.editage.com)for the English language editing.This study was funded by the Grants-in-Aid for Scientific Research(C)18K08973(to TI)and(C)21K09180(to TI).The funders had no roles in the study design,data collection,and interpretation of results.

10.1016/j.hest.2023.11.006

评论